Pr François Ghiringhelli

Spécialité

Oncologue médical, expert digestif

Hôpital

Centre Georges-François Leclerc (Dijon)

Derniers articles

• Surrogate markers of intestinal dysfunction associated with survival in advanced cancers. (1 déc. 2025)
• NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate. (10 avr. 2025)
• The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs. (7 avr. 2025)
• Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies. (6 mars 2025)
• Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer. (20 févr. 2025)